Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma
Authors:
Open Access
- 5 June 2019
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 17 (1) , 1-13
Abstract
Intratumoral immune infiltrates have manifested a robust prognostic signature in patients with hepatocellular carcinoma (HCC). We hypothesized that a novel tissue-related immune signature (TRIS) could improve the prediction of postoperative survival for patients diagnosed with early/intermediate HCC. Twenty-eight immune features were immunohistochemically examined on 352 HCC specimens. The LASSO Cox regression model was used to construct a five-feature-based TRIS. The univariate and multivariate Cox analyses were performed. Based on independent predictors, the immune-clinical prognostic index (ICPI) was established. Performance assessment was measured with C-index and compared with seven traditional staging systems. The independent validation cohort (n = 393) was included to validate the model. By using the LASSO method, the TRIS were constructed on the basis of five immune features, CD3intratumoral (T), CD27T, CD68peritumoral (P), CD103T, and PD1T. Multivariate Cox analysis showed that the TRIS was an independent prognostic predictor. In the training cohort, γ-glutamyl transferase, tumor diameter, tumor differentiation, and TRIS were incorporated into the ICPI. The ICPI presented satisfactory discrimination ability, with C-index values of 0.691 and 0.686 in the training and validation cohorts, respectively. Compared with seven conventional staging systems (C-index, training cohort, 0.548–0.597; validation cohort, 0.519–0.610), the ICPI exhibited better performance for early/intermediate-stage HCCs. Further, the patients were categorized into three subgroups with X-tile software, and the stratified ICPI presented a superior corrected Akaike information criterion and homogeneity in both cohorts. Our ICPI was a useful and reliable prognostic tool which may offer good individualized prediction capability for HCC patients with early/intermediate stage.Keywords
Funding Information
- National High Technology Research and Development Program (863 Program) of China (2015AA020401)
- National Natural Science Foundation of China (81472674, 81502486)
- Shanghai Committee of Science and Technology, China (No. 16JC1404000)
- Shu Guang project of Shanghai Municipal Education Commission and Shanghai Education Development Foundation (13SG04)
- Shanghai Municipal Science and Technology Major Project (2018SHZDZX05)
This publication has 54 references indexed in Scilit:
- ImmunoScore SignatureAnnals of Surgery, 2018
- Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell SequencingCell, 2017
- Global Cancer Incidence and Mortality Rates and Trends—An UpdateCancer Epidemiology, Biomarkers & Prevention, 2016
- Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinomaGut, 2015
- Prognostic Nomograms for Prediction of Recurrence and Survival After Curative Liver Resection for Hepatocellular CarcinomaAnnals of Surgery, 2015
- Immune signature of tumor infiltrating immune cells in renal cancerOncoImmunology, 2015
- Epigenetic reprogramming modulates malignant properties of human liver cancerHepatology, 2014
- Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+ T cells and successful immunotherapy against chronic viral liver infectionNature Immunology, 2013
- Infiltrating Memory/Senescent T Cell Ratio Predicts Extrahepatic Metastasis of Hepatocellular CarcinomaAnnals of Surgical Oncology, 2011
- Staging of Hepatocellular CarcinomaAnnals of Surgery, 2007